The synergy of linagliptin and empagliflozin in catering to diabetes mellitus in Pakistan
Diabetes is rapidly increasing globally, especially in low- and middle-income countries, with Pakistan ranking third in prevalence, having 33 million people. The lack of adherence to the first-line treatment, metformin, mainly due to gastrointestinal side effects, is a significant concern. A novel...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Pakistan Medical Association
2025-01-01
|
| Schriftenreihe: | Journal of the Pakistan Medical Association |
| Schlagworte: | |
| Online-Zugang: | https://jpma.org.pk/index.php/public_html/article/view/11145 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|